Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, 1, 67100, L'Aquila, Italy.
Department of Radiologic Sciences, Azienda Ospedaliero Universitaria Ospedali Riuniti, Università Politecnica Delle Marche, Ancona, Italy.
Radiol Med. 2021 Aug;126(8):1085-1094. doi: 10.1007/s11547-021-01372-6. Epub 2021 May 18.
This study evaluated the ability of T2 mapping magnetic resonance imaging at 3 T, in addition to morphological sequences, to assess efficacy of platelet-rich plasma (PRP) injections, characterizing qualitatively and quantitatively the grade of knee cartilage repair in patients with patellofemoral chondropathy. We retrospectively studied 34 patients (22 men, 12 women, mean age 41.8 years, including 22 men) with patellofemoral knee chondropathy, who underwent intra-articular PRP injections and completed a clinical and instrumental follow-up. As control group, we evaluated 34 patients who underwent non-operative therapy. All patients were submitted to clinical (using VAS and WOMAC index) and imaging studies with 3 T magnetic resonance with cartilage analysis with T2 mapping sequences for cartilage analysis before and after treatment. In the study group, mean pre-treatment T2 relaxation time values were 44.2 ± 2.5 ms, considering all articular cartilage compartments, with significant reduction at the follow-up (p < 0.001). At the index compartment, mean pre-treatment T2 relaxation times values were 47.8 ± 3.6 ms, with statistically significant reduction at the follow-up (p < 0.001). Evaluation of focal cartilage lesions reported pre-treatment mean T2 value of 70.1 ± 13.0 ms and post-treatment mean value of 59.9 ± 4.6 ms (p < 0.001). From a clinical point of view, the pre-treatment WOMAC and VAS scores were 18.3 ± 4.5 and 7 (IQR:6-7.2), respectively; the post-treatment values were 7.3 ± 3.2 and 2 (IQR: 1.7-3.0), respectively (p < 0.001). In the control group, despite clinical improvement, we didn't find significant T2 values change during the follow-up period. In conclusion, T2 mapping is a valuable indicator for chondropathy and treatment-related changes over time.
本研究评估了 3T 下 T2 映射磁共振成像(MRI)除形态学序列外,在评估富血小板血浆(PRP)注射疗效方面的能力,定性和定量评估髌股关节软骨病患者膝关节软骨修复的程度。我们回顾性研究了 34 名髌股膝关节软骨病患者(22 名男性,12 名女性,平均年龄 41.8 岁,包括 22 名男性),他们接受了关节内 PRP 注射,并完成了临床和仪器随访。作为对照组,我们评估了 34 名接受非手术治疗的患者。所有患者均接受了临床(使用 VAS 和 WOMAC 指数)和影像学研究,包括使用 3T MRI 进行软骨分析,使用 T2 映射序列进行软骨分析,在治疗前后进行。在研究组中,所有关节软骨节段的平均治疗前 T2 弛豫时间值为 44.2±2.5ms,随访时显著降低(p<0.001)。在指数节段,治疗前 T2 弛豫时间值的平均值为 47.8±3.6ms,随访时显著降低(p<0.001)。对焦点软骨病变的评估报告治疗前平均 T2 值为 70.1±13.0ms,治疗后平均 T2 值为 59.9±4.6ms(p<0.001)。从临床角度来看,治疗前 WOMAC 和 VAS 评分分别为 18.3±4.5 和 7(IQR:6-7.2);治疗后分别为 7.3±3.2 和 2(IQR:1.7-3.0)(p<0.001)。在对照组中,尽管临床改善,但我们在随访期间未发现 T2 值有显著变化。总之,T2 映射是评估软骨病和随时间变化的治疗相关变化的有价值的指标。